In general, these findings demonstrated that our six IAG signature not only played a critical role in stratifying melanoma patients and predicting OS but also was significantly connected with ICB immunotherapy, BCR/TCR richness, immune cell populations, and immune checkpoints. The gene discussed is BCR; the disease is melanoma.